Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)

Ok Seon Kwon; Haeseung Lee; Hyeon Joon Kong; Eun Ji Kwon; Ji Eun Park; Wooin Lee; Seungmin Kang; Mirang Kim; Wankyu Kim; Hyuk Jin Cha

doi:10.1038/s41388-021-01642-7

Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)

Ok Seon Kwon, Haeseung Lee, Hyeon Joon Kong, Eun Ji Kwon, Ji Eun Park, Wooin Lee, Seungmin Kang, Mirang Kim, Wankyu Kim, Hyuk Jin Cha

Department of Life Science

Research output: Contribution to journal › Comment/debate

Abstract

In the originally published version, the grant number of Dr Kim Wankyu was wrongly described in the original paper by mistake. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from H-JC, NRF-2019R1C1C1008710 from O-SK and NRF- 2017M3C9A5028690 from WK). The original version was corrected.

Original language	English
Pages (from-to)	1921
Number of pages	1
Journal	Oncogene
Volume	40
Issue number	10
DOIs	https://doi.org/10.1038/s41388-021-01642-7
State	Published - 10 Mar 2021

Bibliographical note

Publisher Copyright:
© 2021, The Author(s), under exclusive licence to Springer Nature Limited.

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41388-021-01642-7

Cite this

Kwon, O. S., Lee, H., Kong, H. J., Kwon, E. J., Park, J. E., Lee, W., Kang, S., Kim, M., Kim, W., & Cha, H. J. (2021). Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2). Oncogene, 40(10), 1921. https://doi.org/10.1038/s41388-021-01642-7

@article{7f006e3e3fc1456c85a84fa79c3201ca,

title = "Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)",

abstract = "In the originally published version, the grant number of Dr Kim Wankyu was wrongly described in the original paper by mistake. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from H-JC, NRF-2019R1C1C1008710 from O-SK and NRF- 2017M3C9A5028690 from WK). The original version was corrected.",

author = "Kwon, {Ok Seon} and Haeseung Lee and Kong, {Hyeon Joon} and Kwon, {Eun Ji} and Park, {Ji Eun} and Wooin Lee and Seungmin Kang and Mirang Kim and Wankyu Kim and Cha, {Hyuk Jin}",

note = "Publisher Copyright: {\textcopyright} 2021, The Author(s), under exclusive licence to Springer Nature Limited.",

year = "2021",

month = mar,

day = "10",

doi = "10.1038/s41388-021-01642-7",

language = "English",

volume = "40",

pages = "1921",

journal = "Oncogene",

issn = "0950-9232",

publisher = "Nature Publishing Group",

number = "10",

}

Kwon, OS, Lee, H, Kong, HJ, Kwon, EJ, Park, JE, Lee, W, Kang, S, Kim, M, Kim, W & Cha, HJ 2021, 'Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)', Oncogene, vol. 40, no. 10, pp. 1921. https://doi.org/10.1038/s41388-021-01642-7

TY - JOUR

T1 - Correction to

T2 - Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)

AU - Kwon, Ok Seon

AU - Lee, Haeseung

AU - Kong, Hyeon Joon

AU - Kwon, Eun Ji

AU - Park, Ji Eun

AU - Lee, Wooin

AU - Kang, Seungmin

AU - Kim, Mirang

AU - Kim, Wankyu

AU - Cha, Hyuk Jin

PY - 2021/3/10

Y1 - 2021/3/10

N2 - In the originally published version, the grant number of Dr Kim Wankyu was wrongly described in the original paper by mistake. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from H-JC, NRF-2019R1C1C1008710 from O-SK and NRF- 2017M3C9A5028690 from WK). The original version was corrected.

AB - In the originally published version, the grant number of Dr Kim Wankyu was wrongly described in the original paper by mistake. This work was supported by a grant from the National Research Foundation of Korea (NRF-2017M3C9A5028691 from H-JC, NRF-2019R1C1C1008710 from O-SK and NRF- 2017M3C9A5028690 from WK). The original version was corrected.

UR - http://www.scopus.com/inward/record.url?scp=85100722183&partnerID=8YFLogxK

U2 - 10.1038/s41388-021-01642-7

DO - 10.1038/s41388-021-01642-7

M3 - Comment/debate

C2 - 33574481

AN - SCOPUS:85100722183

SN - 0950-9232

VL - 40

SP - 1921

JO - Oncogene

JF - Oncogene

IS - 10

ER -

Correction to: Connectivity map-based drug repositioning of bortezomib to reverse the metastatic effect of GALNT14 in lung cancer (Oncogene, (2020), 39, 23, (4567-4580), 10.1038/s41388-020-1316-2)

Abstract

Bibliographical note

UN SDGs

Access to Document

Fingerprint

Cite this